Skip to main content
logo
Epigenomics AG (FRA:ECX)
Germany flag Germany · Delayed Price · Currency is EUR
0.8920
0.00 (0.00%)
At close: Jan 30, 2026

Epigenomics AG Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-3.35-4.46-17.3-2.43-11.69
Depreciation & Amortization
0.011.357.020.340.34
Other Amortization
---0.080.19
Loss (Gain) From Sale of Assets
--0-0.01-
Loss (Gain) From Sale of Investments
2.28----
Stock-Based Compensation
---0.10.63
Other Operating Activities
0.23-2.631.47-1.260.04
Change in Accounts Receivable
---0.18-0.16
Change in Inventory
---1.86-0.050.19
Change in Accounts Payable
-0.470.380.25-1.190.42
Change in Unearned Revenue
----0.010.07
Change in Other Net Operating Assets
0.1-0.35-0.20.090.39
Operating Cash Flow
-1.2-5.71-10.63-4.15-9.57
Capital Expenditures
---0.09-0.04-0.01
Sale of Property, Plant & Equipment
-0.03---
Sale (Purchase) of Intangibles
---0.05--0.01
Investment in Securities
--0-0.98-
Other Investing Activities
0.030.040.10.010.02
Investing Cash Flow
0.030.07-0.040.960
Long-Term Debt Issued
---22-
Total Debt Issued
---22-
Long-Term Debt Repaid
----0.27-0.27
Net Debt Issued (Repaid)
---21.73-0.27
Issuance of Common Stock
---2.174
Repurchase of Common Stock
--0.05---0.02
Other Financing Activities
--0.01-0.45-2.28-0.73
Financing Cash Flow
--0.06-0.4521.622.98
Foreign Exchange Rate Adjustments
---0.021.06-0
Net Cash Flow
-1.18-5.7-11.1419.48-6.59
Free Cash Flow
-1.2-5.71-10.71-4.19-9.58
Free Cash Flow Margin
--1684.66%-1191.77%-67.50%-1137.89%
Free Cash Flow Per Share
-1.37-6.69-13.17-7.47-33.16
Cash Interest Paid
--0.020.02-
Cash Income Tax Paid
---0.020.02
Levered Free Cash Flow
-0.84-1.02-1.57-2.03-6.25
Unlevered Free Cash Flow
-0.84-1.02-1.52-2-6.22
Change in Working Capital
-0.380.04-1.81-0.990.91
Source: S&P Global Market Intelligence. Standard template. Financial Sources.